The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells-Reference-Cited by-同舟云学术

The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells

Published:2016-06-29 Issue:7 Volume:5 Page:e1195535
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Gonçalves Silva Isabel,Rüegg Laura,Gibbs Bernhard F.,Bardelli Marco,Fruehwirth Alexander,Varani Luca,Berger Steffen M.,Fasler-Kan Elizaveta,Sumbayev Vadim V.

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2016.1195535

Reference26 articles.

1. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells

2. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia

3. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression

4. Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells

5. The immune receptor Tim-3 mediates activation of PI3 kinase/mTOR and HIF-1 pathways in human myeloid leukaemia cells

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-targeting CD33/CD123 NANOBODY T-cell engager with potent anti-AML activity and good safety profile;Blood Advances;2024-04-26

2. Galectin-9, a pro-survival factor inducing immunosuppression, leukemic cell transformation and expansion;Molecular Biology Reports;2024-04-25

3. TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1;BMC Cancer;2024-01-24

4. NK cell-based tumor immunotherapy;Bioactive Materials;2024-01

5. A T-cell receptor as a promising immunotherapeutic target in acute myeloid leukemia: expression of T cell immunoglobulin and mucin-containing-3 on bone marrow hematopoietic cells;The Egyptian Journal of Haematology;2024-01